scholarly journals Patients’ Expectations And Intentions To Receive Medication Counseling From Community Pharmacists

2014 ◽  
Vol 17 (3) ◽  
pp. A23
Author(s):  
E.A. Ferries ◽  
M.L. Fleming ◽  
M.D. Hatfield ◽  
N. Atreja ◽  
A. Yucel ◽  
...  
Keyword(s):  
Community Pharmacists ◽  
Medication Counseling ◽  
To Receive

scholarly journals A GLOBAL PICTURE OF EXTENDED PHARMACY SERVICES, PERCEPTIONS, AND BARRIERS TOWARD ITS PERFORMANCE: A SYSTEMATIC REVIEW

2017 ◽  
Vol 10 (11) ◽  
pp. 417 ◽  
Author(s):  
Nazri Nordin ◽  
Mohamed Azmi Ahmad Hassali, ◽  
Azmi Sarriff
Keyword(s):  
Community Pharmacy ◽  
Health Care Professionals ◽  
Literature Search ◽  
Pharmacy Practice ◽  
Community Pharmacists ◽  
Database Searching ◽  
Medication Counseling ◽  
Community Pharmacy Practice ◽  
Wide Range ◽  
Negative Perceptions

  Objective: The aims of this review were to observe extended services performed in the community pharmacy settings, perceptions among community pharmacists (CPs), general practitioners (GPs), and customers of these extended services and barriers toward its performance.Methods: A literature search was conducted, using Google Scholar as database, searching for full access texts. The inclusive texts fulfilled the inclusion criteria.Results: A total of 22 texts had been systematically reviewed, noting a wide range of extended services performed in community pharmacy settings. Medication counseling or review and promoting health educations were noted as the most extended services performed. It is also noted that CPs indicated that these extended services could establish working relationship with other health-care professionals. However, it is noted that among the barriers toward extended services were lack of knowledge, skills, and time to perform.Conclusion: As a conclusion, the community pharmacy practice is evolving, transforming into more patient-oriented even though there are some negative perceptions among the customers and GPs toward these extended services. Barriers to the performance of these extended services should be intervened.  

Assessing patient satisfaction after comprehensive medication review including oral chemotherapy adherence with an oncology pharmacist at the Southcoast Centers for Cancer Care (SCCC).

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e19241-e19241
Author(s):  
Patrick John Skeffington ◽  
Laura Haynes ◽  
Donna Raymond ◽  
Heather McCarthy
Keyword(s):  
Patient Satisfaction ◽  
Community Pharmacists ◽  
Oral Chemotherapy ◽  
Third Party ◽  
Effective Counseling ◽  
Open Discussion ◽  
Specialty Pharmacy ◽  
Strongly Agree ◽  
Pharmacist Services ◽  
To Receive

e19241 Background: Use of oral chemotherapy has increased dramatically over the past few years. Patient often are required to obtain their oral chemotherapy from a third party specialty pharmacy while continuing to receive their other medications from other pharmacies. Many community pharmacists lack knowledge about oral chemotherapy, safe practices, or effective counseling of these medications. Objective: To assess patient perception and satisfaction of a pharmacist 1 on 1 appointment when starting oral chemotherapy. Methods: A program was designed at SCCC whereby all patients starting oral chemotherapy are scheduled for an appointment with a clinical oncology pharmacist to update medication lists, evaluate adherence, and conduct a "brown bag" visit where patients are allowed to voice concerns and ask questions. After each appointment patients were asked to fill out a short survey, The Patient Satisfaction with Pharmacist Services Questionnaire (PSPSQ 2.0). Results: PSPSQ 2.0 uses a Likert scale ranging from 1 to 4. From October 2016 to June 2019, 174 patients had appointments and 55 returned their surveys yielding a 30% response rate. Average scores hovered around 1 (strongly agree) for each question except question 11 (the only negatively worded question). Question 11 averaged 3.1; Disagree. Conclusions: Patients who were seen by an oncology clinical pharmacist to evaluate adherence, participate in a "brown bag" clinic and open discussion, found the appointment worthy of their time.

Assessment of the Pharmacy Service Needs of HIV-Positive Outpatients Receiving Zidovudine

1992 ◽  
Vol 26 (5) ◽  
pp. 621-626 ◽  
Author(s):  
Rafelina Greco ◽  
Lesley Lavack ◽  
John Rovers
Keyword(s):  
Hiv Risk ◽  
Pharmacy Service ◽  
Hiv Positive ◽  
Service Needs ◽  
For Profit ◽  
Not For Profit ◽  
Medication Counseling ◽  
Other Information ◽  
Drug History ◽  
To Receive

OBJECTIVE: To determine the pharmacy service needs of HIV-positive outpatients. DESIGN: Anonymous mail-in survey. SETTING: Accredited, not-for-profit, outpatient pharmacy. PATIENTS: A total of 226 men receiving refill prescriptions for zidovudine. Relevant demographics: For 91 percent, homosexual behavior was the primary HIV risk factor, 75 percent were HIV positive with low CD4+ count; 68 percent had been receiving zidovudine for less than 12 months. MEASUREMENTS: Survey questions determined patients' past experience and satisfaction with pharmacy services, description of pharmacy service needs, drug history, and sociodemographics. MAIN RESULTS: Confidentiality was desired by 90 percent of patients. Patients also expected to receive private medication counseling on zidovudine routinely and to receive other information upon request. Twenty patients expected no medication counseling. Such patients were more likely to have contracted HIV by transfusion or intravenous drug abuse (p<0.05). CONCLUSIONS: The perceived pharmacy service needs of outpatients taking zidovudine can reasonably be met in all ambulatory settings. Pharmacists must be aware that all patients do not have the same needs and should tailor their activities to the needs expressed by individual patients.

scholarly journals Community pharmacists’ knowledge of COPD, and practices and perceptions of medication counseling of COPD patients

2018 ◽  
Vol Volume 13 ◽  
pp. 2065-2074 ◽  
Author(s):  
Juha Markus Heikkilä ◽  
Stina Parkkamäki ◽  
Johanna Salimäki ◽  
Sari Westermarck ◽  
Marika Pohjanoksa-Mäntylä
Keyword(s):  
Community Pharmacists ◽  
Medication Counseling ◽  
Copd Patients

Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario

2020 ◽  
Vol 26 (8) ◽  
pp. 1903-1911
Author(s):  
Kathy Vu ◽  
Aliya Pardhan ◽  
Nita Lakhani ◽  
Stephanie Metcalfe ◽  
Mindaugas Mozuraitis ◽  
...  
Keyword(s):  
Anticancer Drugs ◽  
Management Practices ◽  
Community Setting ◽  
Community Pharmacists ◽  
Specialized Knowledge ◽  
Oncology Education ◽  
Study Support ◽  
Almost All ◽  
To Receive ◽  
Question Survey

Background Toxicity management is a challenge with cancer treatment, including oral anticancer drugs. A review of claims data showed that a majority of publically funded oral anticancer drugs were filled in the community where pharmacists may not necessarily possess the specialized knowledge, skills, and experience required to provide effective patient care. A survey of community pharmacists in Ontario was conducted to identify the behaviours and preferences of community pharmacists specific to the management of treatment-related toxicities in order to standardize cancer care in this area. Methods An electronic questionnaire was distributed to approximately 5000 community pharmacists. The 21-question survey gathered information on the demographic profile of the pharmacists, basic geographic and socioeconomic variables associated with their practice setting, current toxicity management practices, education and training needs, and preferences for communicating with other providers. Results Of 349 pharmacists, almost all (94.9%) were interested in managing chemotherapy-related toxicities as part of their work, but the majority (77.1%) did not feel that their current level of pharmacy training has provided them with an oncology education sufficient for the demands of their practice. Approximately 52% of respondents indicated that they have reached out to the health care provider at a cancer centre, and of those, 72.7% reported that their questions were resolved within 48 h. More than half of all survey respondents (53.9%) indicated that they would prefer to receive a response within 12 h from cancer centres. Conclusions The results of this study support the need to provide community pharmacists with oncology-specific training and timely correspondences from providers at prescribing institutions in order to manage toxicities.

scholarly journals Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand–foot syndrome in cancer patients: a retrospective study

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Nobuhiko Nakamura ◽  
Hiroki Shiraiwa ◽  
Yasuhiro Haruna ◽  
Tomoki Ichijima ◽  
Tomoko Takeda ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Adjuvant Chemotherapy ◽  
Pharmaceutical Care ◽  
Cancer Patients ◽  
Medical Records ◽  
Community Pharmacists ◽  
Conventional Care ◽  
Control Group ◽  
Hand Foot Syndrome ◽  
To Receive

Abstract Background Pharmaceutical care of capecitabine-related hand–foot syndrome (HFS) is extremely important to avoid the progression of the syndrome. Protocol-based pharmacotherapy management (PBPM) of HFS by community pharmacists has been introduced in our community, whereby the community pharmacist instructs patients to use steroid creams if they develop HFS of grade 2 or higher. This study aimed to evaluate the effectiveness of PBPM in cancer patients with HFS by comparing it to conventional pharmaceutical care using monitoring reports for pharmacotherapy management by community pharmacists. Methods From September 2017 to August 2019, we retrospectively investigated the medical records of 396 cancer patients who received capecitabine adjuvant chemotherapy. Before PBPM implementation, conventional pharmaceutical care was administered from September 2017 to August 2018; these patients served as the control group. Care was switched to PBPM in September 2018, and PBPM was applied from September 2018 to August 2019; these patients served as the PBPM group. We excluded patients who received both conventional pharmaceutical care and PBPM. We categorized all cases into two groups: age ≤ 69 years and age ≥ 70 years. Results In all, 396 cases were included, of which 227 were ineligible, such as those of cancer patients who received both conventional pharmaceutical care and PBPM. Among patients aged higher than 70 years, the incidence and severity of HFS associated with PBPM were significantly lower than those associated with conventional care (grade 0: 59.5% [44/74] vs. 30.6% [11/36], grade 1: 33.8% [25/74] vs. 63.9% [23/36]). All patients continued to receive the capecitabine, HFS severity improved to grade 1 during the study period, and treatment of HFS was not stopped. Conclusion Our findings suggest that PBPM is effective for addressing capecitabine-related HFS among cancer patients aged higher than 70 years, in that it helps prevent an increase in HFS severity.

On the Front Line of Smoking Cessation: Education Needs of Community Pharmacists

2005 ◽  
Vol 138 (3) ◽  
pp. 26-31 ◽  
Author(s):  
Joan M. Brewster ◽  
J. Charles Victor ◽  
Mary Jane Ashley ◽  
Claudine Laurier ◽  
Rachel Dioso ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Health Care Professionals ◽  
Community Pharmacists ◽  
Pharmacy Education ◽  
Additional Information ◽  
Quit Smoking ◽  
Wide Range ◽  
Canadian Provinces ◽  
To Receive ◽  
And Training

Background: Nicotine replacement therapy (NRT) is now available without prescription, and pharmacists have an opportunity to be the primary health care professionals advising patients who want to try this smoking cessation aid. Undergraduate pharmacy education in Canada incorporates some tobacco-related training, and continuing education opportunities are available. However, there are no published reports of the self-reported educational needs of a broad sample of practising Canadian community pharmacists with regard to smoking cessation. Methods: Practising community pharmacists in four Canadian provinces were surveyed about their tobacco-related education and knowledge, practice environment, practices related to helping people quit smoking, needs for further information and training, and methods by which this information might be delivered. Results: A corrected response rate of 72% was obtained, giving a weighted n of 960 responses. Most Canadian community pharmacists reported that they would find it helpful to receive additional information or training on a wide range of smoking cessation topics, such as behavioural counselling techniques and motivating patients to quit. Pharmacists who reported that they were familiar with aids such as Helping Your Patients Quit Smoking: A Cessation Guide for Pharmacists (Canadian Pharmacists Association) and who reported that the guide had led them to make changes in their practice were more likely to report that additional information or training would be helpful. Pharmacists who perceived their tobacco-related clinical and non-clinical roles to be important were more likely to report that additional training would be helpful than were those who perceived these roles as less important. Conclusions: Although most Canadian community pharmacists would find it helpful to receive additional smoking-related information and training, those who perceive this to be an important activity and who are already using available materials showed the most interest. The challenge to Canadian pharmacy educators is to encourage the enthusiasm of those already interested in helping their patients to quit smoking, while raising the level of interest and motivation among all community pharmacists.

scholarly journals Identifying Barriers and Facilitators at Affect Community Pharmacists' Ability to Engage Children in Medication Counseling: A Pilot Study

2017 ◽  
Vol 22 (6) ◽  
pp. 412-422 ◽  
Author(s):  
Olufunmilola Abraham ◽  
Dayna S. Alexander ◽  
Loren J. Schleiden ◽  
Delesha M. Carpenter
Keyword(s):  
Pharmacy Practice ◽  
Community Pharmacists ◽  
Barriers And Facilitators ◽  
Pharmacy Staff ◽  
Practice Experience ◽  
Medication Counseling ◽  
Interview Guide ◽  
Child Friendly ◽  
Communication Approach ◽  
Staff Experiences

OBJECTIVES This study aimed to describe the barriers and facilitators that influence community pharmacists' ability to provide medication counseling to pediatric patients. METHODS Semistructured interviews (n = 16) were conducted with pharmacy staff at 3 community pharmacies in 2 Eastern states. The interview guide elicited pharmacy staff experiences interacting with children and their perceived barriers and facilitators to providing medication counseling. Transcripts were reviewed for accuracy and a codebook was developed for data analysis. NVivo 10 was used for content analysis and identifying relevant themes. RESULTS Ten pharmacists and 6 pharmacy technicians were interviewed. Most participants were female (69%), aged 30 to 49 years (56%), with ≥5 years of pharmacy practice experience. Eight themes emerged as barriers to pharmacists' engaging children in medication counseling, the most prevalent being the child's absence during medication pickup, the child appearing to be distracted or uninterested, and having an unconducive pharmacy environment. Pharmacy staff noted 7 common facilitators to engaging children, most importantly, availability of demonstrative and interactive devices/technology, pharmacist demeanor and communication approach, and having child-friendly educational materials. CONCLUSIONS Findings suggest that pharmacy personnel are rarely able to engage children in medication counseling because of the patient's absence during medication pickup; however, having child-friendly materials could facilitate interactions when the child is present. These findings can inform programs and interventions aimed at addressing the barriers pharmacists encounter while educating children about safe and appropriate use of medicines.

Sign in / Sign up

Export Citation Format

Share Document